Cancer testing market

406 views
347 views

Published on

Renub Research has announced the addition of the "Cancer Test Market & Forecast, Companies Cancer Test Platform, Pipeline Analysis and Clinical Trials - Global" report to its offering

Renub Research study titled “Cancer Test Market & Forecast, Companies Cancer Test Platform, Pipeline Analysis and Clinical Trials - Global” provides a comprehensive assessment of the fast-evolving, high-growth of Cancer Test market segment. This 277 page report with 52 Figures and 57 Tables studies the Cancer Test Platform of 20 Companies. This report is broadly divided into 8 chapters.

A. Global – Cancer Testing Market and New Cases (Chapter 2)
B. Global – Cancer Testing Market Share & Forecast (Chapter 3)
C. Global – Segment Wise Cancer Testing Market & Forecast (Chapter 4)
D. Global – Organ Specific Cancer Testing Market & Forecast (Chapter 5)
E. Cancer Diagnostics – Companies Novel Test Platform Analysis (Chapter 6)
F. Geographic Region – Number of New Cancer Cases (Chapter 7)
G. Number of New Cancer Cases by Site - Geographic Region Distribution & Clinical Trials (Chapter 8)

Click here to view the report details: http://www.renub.com/report/cancer-test-market-forecast-companies-cancer-test-platform-pipeline-analysis-and-clinical-trials---global-125

Contact Us

Andy Hill
Sr. Manager - Publisher Relation
Sales & Marketing Div
Renub Research
Email: info@renub.com
Phone: +1-678-302-0700 (USA) +91-120-254-5750 (India)
Web: http://www.renub.com/

Published in: Business, Health & Medicine
0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total views
406
On SlideShare
0
From Embeds
0
Number of Embeds
0
Actions
Shares
0
Downloads
6
Comments
0
Likes
0
Embeds 0
No embeds

No notes for slide

Cancer testing market

  1. 1. Renub Research www.renub.com Cancer Test Market & Forecast, Companies Cancer Test Platform, Pipeline Analysis and Clinical Trials - Global Published: October, 2013 Copyright © 2013 Renub Research – All Rights Reserved
  2. 2. Cancer is the second-leading cause of death and disability in the world, behind only heart disease. More people die from cancer every year around the world than AIDS, Tuberculosis and Malaria combined. Cancer testing has tremendous growth opportunities for the next five years. According to the National Cancer Institute (NCI), 85% of cancer patients are treated in community-based, private practice oncology settings. Accordingly, global expansion of cancer marker technologies may be fueled by an increased marketing of new diagnostic tests to physicians. During the next five years, the worldwide cancer diagnostics market is promising to be an exciting, dynamic and rapidly expanding field. The anticipated technological breakthroughs will create numerous opportunities for determining genetic predisposition, detecting specific tumors, and monitoring biological response to cancer therapy. The global cancer test market is expected to be more than US$ 14 Billion by 2018. Renub Research study titled “Cancer Test Market & Forecast, Companies Cancer Test Platform, Pipeline Analysis and Clinical Trials - Global” provides a comprehensive assessment of the fast-evolving, high-growth of Cancer Test market segment. This 277 page report with 52 Figures and 57 Tables studies the Cancer Test Platform of 20 Companies. This report is broadly divided into 8 chapters. A. Global – Cancer Testing Market and New Cases (Chapter 2) B. Global – Cancer Testing Market Share & Forecast (Chapter 3) C. Global – Segment Wise Cancer Testing Market & Forecast (Chapter 4) D. Global – Organ Specific Cancer Testing Market & Forecast (Chapter 5) E. Cancer Diagnostics – Companies Novel Test Platform Analysis (Chapter 6) F. Geographic Region – Number of New Cancer Cases (Chapter 7) G. Number of New Cancer Cases by Site - Geographic Region Distribution & Clinical Trials (Chapter 8) Global – Segment Wise Cancer Testing Market (To 2018) (Chapter No. 4)  Prostate Specific Antigen (PSA) Test Market & Forecast  Fecal Occult Blood Test Market & Forecast  Fluorescent In-Situ Hybridization (FISH) Test Market & Forecast  Human Papilloma Virus (HPV) Test Market & Forecast  Bladder Test Market & Forecast
  3. 3.  Serum Based Cancer Markers Market & Forecast  Pharmacognostic Histology Market & Forecast  Flow Cytometry Market & Forecast  Other Test Market & Forecast Global – Organ Specific Cancer Testing Market (To 2018) (Chapter No. 5)  Bladder Cancer Test Market & Forecast  Breast Cancer Test Market & Forecast  Cervical Cancer Test Market & Forecast  Colorectal (Colon) Cancer Test Market & Forecast  Ovarian Cancer Test Market & Forecast  Prostate Cancer Test Market & Forecast  Liver Cancer Test Market & Forecast  Flow Cytometry Market & Forecast  Other Organ Specific Cancer Test Market & Forecast Cancer Diagnostics – Companies Novel Test Platform Analysis (Chapter No. 6) 1 Abbott 11 Genomic Health Inc 2 Radient Pharmaceuticals 12 QIAGEN Marseille (Earlier Ipsogen) 3 BD Diagnostics 13 Myriad Genetics, Inc 4 Beckman Coulter, Inc. 14 Panacea Pharmaceuticals, Inc. 5 BioCurex 15 Qiagen 6 bioMerieux 16 Siemens Heathcare Diagnostics 7 Cepheid 17 Roche 8 CytoCore Inc. 18 Ventana Medical Systems 9 DiagnoCure, Inc 19 Trovagene Inc 10 Gen-Probe, Inc. 20 Vermillion, Inc © Renub Research Page 3 of 19
  4. 4. Geographic Region – Number of New Cancer Cases (To 2020) (Chapter No. 7) 1. Africa 4. Europe 2. Americas 5. Oceania 3. Asia Number of New Cancer Cases by Site - Geographic Region Distribution (To 2020) (Chapter 8) 1 Bladder Cancer 15 Myeloma 2 Brain Cancer 16 Nasopharynx 3 Breast Cancer 17 Non-Hodgkin Lymphoma 4 Cervix Cancer 18 Oesophagus 5 Colorectal Cancer 19 Oral Cavity 6 Corpus Cancer 20 Other Pharynx 7 Hodgkin’s Lymphoma 21 Ovary Cancer 8 Kaposi Sarcoma 22 Pancreas Cancer 9 Kidney Cancer 23 Prostate Cancer 10 Larynx Cancer 24 Stomach Cancer 11 Leukaemia 25 Testis Cancer 12 Liver Cancer 26 Thyroid Cancer 13 Lung Cancer 27 Other Sites 14 Melanoma Cancer Site - Clinical Trials (Chapter 8) 1. Bladder Cancer 4. Liver Cancer 2. Cervical Cancer 5. Ovarian Cancer 3. Colorectal Cancer 6. Prostate Cancer Data Sources This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by Renub Research team of industry experts. © Renub Research Page 4 of 19
  5. 5. Primary sources include industry surveys and telephone interviews with industry experts. Secondary sources information and data has been collected from various printable and nonprintable sources like search engines, News websites, Government Websites, Trade Journals, White papers, Government Agencies, Magazines, Newspapers, Trade associations, Books, Industry Portals, Industry Associations and access to more than 500 paid databases. © Renub Research Page 5 of 19
  6. 6. Table of Contents 1. Executive Summary 2. Global – Cancer Testing Market and New Cases 2.1 2.2 3. Global – Cancer Testing Market (2010 – 2018) Global – Number of New Cancer Cases (2009 – 2020) Global – Cancer Testing Market Share 3.1 3.2 4. Global – Segment Wise Cancer Testing Market Share& Forecast (2011 – 2018) Global – Organ Specific Cancer Testing Market Share & Forecast (2010 – 2018) Global – Segment Wise Cancer Testing Market 4.1 4.2 Fecal Occult Blood Test Market & Forecast (2009 – 2018) 4.3 Fluorescent In-Situ Hybridization (FISH) Test Market & Forecast (2010 – 2018) 4.4 Human PapillomaVirus (HPV) Test Market & Forecast (2010 – 2018) 4.5 Bladder Test Market & Forecast (2010 – 2018) 4.6 Serum Based Cancer Markers Market & Forecast (2008 – 2018) 4.7 Pharmacognostic Histology Market & Forecast (2011 – 2018) 4.8 Flow Cytometry Market & Forecast (2011 – 2018) 4.9 5. Prostate Specific Antigen (PSA) Test Market & Forecast (2010 – 2018) Other Test Market& Forecast (2011 – 2018) Global – Organ Specific Cancer Testing Market 5.1 Bladder Cancer Test Market& Forecast (2010 – 2018) 5.2 Breast Cancer Test Market & Forecast (2010 – 2018) 5.3 Cervical Cancer Test Market & Forecast (2010 – 2018) 5.4 Colorectal (Colon) Cancer Test Market & Forecast (2010 – 2018) 5.5 Ovarian Cancer Test Market & Forecast (2010 – 2018) © Renub Research Page 6 of 19
  7. 7. 5.6 5.7 Liver Cancer Test Market & Forecast (2010 – 2018) 5.8 6. Prostate Cancer Test Market & Forecast (2010 – 2018) Other Organ Specific Cancer Test Market & Forecast (2010 – 2018) Cancer Diagnostics– Companies Novel Test Platforms & Pipeline Analysis (20 Companies Analysis) 6.1 Abbott 6.1.1 Abbott – Cancer Test Platforms 6.1.2 Abbott's Cancer Pipeline Analysis 6.2 Radient Pharmaceuticals 6.2.1 6.3 Radient Pharmaceuticals – Cancer Test Platforms BD Diagnostics 6.3.1 BD Diagnostics – Cancer Test Platform 6.3.2 BD Diagnostics Pipeline Analysis 6.4 Beckman Coulter, Inc. 6.4.1 6.5 Beckman Coulter, Inc. – Cancer Test platform BioCurex 6.5.1 BioCurex – Cancer Test Platform 6.5.2 BioCurex – Pipeline Analysis 6.6 bioMerieux 6.6.1 bioMerieux – Cancer Test Platform 6.6.2 bioMérieux - Pipeline Analysis 6.7 Cepheid 6.7.1 Cepheid – Cancer Test Platform 6.7.2 Cepheid – Pipeline Analysis 6.8 CytoCore Inc. © Renub Research Page 7 of 19
  8. 8. 6.8.1 CytoCore Inc. – Cancer Test Platform 6.8.2 CytoCore Inc. – 6.9 Pipeline Analysis DiagnoCure, Inc. 6.9.1 DiagnoCure, Inc. – Cancer Test Platform 6.9.2 DiagnoCure Inc. – Pipeline Analysis 6.10 Gen-Probe, Inc. 6.10.1 6.11 Gen-Probe, Inc. – Cancer Test Platform Genomic Health Inc. 6.11.1 Genomic Health Inc. – Cancer Test Platform 6.11.2 GenomicHealth, Inc. – Pipeline Analysis 6.12 QIAGEN Marseille (Earlier Ipsogen) 6.12.1 6.13 QIAGEN Marseille – Cancer Test Platform Myriad Genetics, Inc 6.13.1 Myriad Genetics, Inc – Cancer Test Platform 6.13.2 Myriad Genetics, Inc – Pipeline Analysis 6.14 Panacea Pharmaceuticals, Inc. 6.14.1 6.15 Panacea Pharmaceuticals, Inc. – Cancer Test Platform Qiagen 6.15.1 Qiagen – Cancer Test Platform 6.15.2 Qiagen – Pipeline Analysis 6.16 Siemens Heathcare Diagnostics 6.16.1 6.17 Siemens Heathcare Diagnostics – Cancer Test Platform Roche 6.17.1 Roche – Cancer Test Platform © Renub Research Page 8 of 19
  9. 9. 6.17.2 6.18 Ventana Medical Systems, Inc. 6.18.1 6.19 Roche – Pipeline Analysis Ventana Medical Systems, Inc. – Cancer Test Platform TrovageneInc. 6.19.1 Trovagene, Inc. – Cancer Test Platform 6.19.2 TrovageneInc. – Pipeline Analysis 6.20 Vermillion, Inc 6.20.1 7. Vermillion, Inc – Cancer Test Platform Geographic Region – Number of New Cancer Cases 7.1 7.2 Americas – Number of New Cancer Cases & Forecast (2009 – 2020) 7.3 Asia – Number of New Cancer Cases & Forecast (2009 – 2020) 7.4 Europe – Number of New Cancer Cases & Forecast (2009 – 2020) 7.5 8. Africa – Number of New Cancer Cases & Forecast (2009 – 2020) Oceania – Number of New Cancer Cases & Forecast (2009 – 2020) Number of New Cancer Cases by Site - Geographic Region Distribution & Clinical Trials 8.1 Bladder Cancer Number of New Cases & Clinical Trials 8.1.1 Bladder Cancer Number of New Cases & Forecast – Geographic Distribution (2009 - 2020) 8.1.2 Bladder Cancer – Tests Being Studied in Clinical Trials 8.2 Brain Cancer Number of New Cases 8.2.1 8.3 Breast Cancer Number of New Cases 8.3.1 8.4 Brain Cancer Number of New Cases & Forecast – Geographic Distribution (2009 - 2020) Breast Cancer Number of New Cases & Forecast – Geographic Distribution (2009 - 2020) Cervix Cancer Number of New Cases & Clinical Trials 8.4.1 Cervix Cancer Number of New Cases & Forecast – Geographic Distribution (2009 -2020) © Renub Research Page 9 of 19
  10. 10. 8.4.2 8.5 Cervical Cancer – Test Being Studied in Clinical Trials Colorectal Cancer Number of New Cases & Clinical Trials 8.5.1 Colorectal Cancer Number of New Cases & Forecast – Geographic Distribution (2009 - 2020) 8.5.2 8.6 Corpus Cancer Number of New Cases 8.6.1 8.7 Colorectal Cancer – Test Being Studied in Clinical Trials Corpus Cancer Number of New Cases & Forecast – Geographic Distribution (2009 - 2020) Hodgkin’s Lymphoma Number of New Cases 8.7.1 Hodgkin’s Lymphoma Number of New Cases & Forecast – Geographic Distribution (2009 - 2020) 8.8 Kaposi Sarcoma Number of New Cases 8.8.1 8.9 Kidney Cancer Number of New Cases 8.9.1 8.10 Larynx Cancer Number of New Cases & Forecast – Geographic Distribution (2009 - 2020) Leukaemia Number of New Cases 8.11.1 8.12 Kidney Cancer Number of New Cases & Forecast – Geographic Distribution (2009 - 2020) Larynx Cancer Number of New Cases 8.10.1 8.11 Kaposi Sarcoma Number of New Cases & Forecast – Geographic Distribution (2009 - 2020) Leukaemia Number of New Cases & Forecast – Geographic Distribution (2009 - 2020) Liver Cancer Number of New Cases & Clinical Trials 8.12.1 Liver Cancer Number of New Cases & Forecast – Geographic Distribution (2009 - 2020) 8.12.2 Liver Cancer – Test Being Studied in Clinical Trials 8.13 Lung Cancer Number of New Cases 8.13.1 Lung Cancer Number of New Cases & Forecast – Geographic Distribution (2009 - 2020) © Renub Research Page 10 of 19
  11. 11. 8.14 Melanoma Number of New Cases 8.14.1 Melanoma Cancer Number of New Cases & Forecast – Geographic Distribution (2009 - 2020) 8.15 Myeloma Number of New Cases 8.15.1 Myeloma Cancer Number of New Cases & Forecast – Geographic Distribution (2009 - 2020) 8.16 Nasopharynx Number of New Cases 8.16.1 Nasopharynx Cancer Number of New Cases & Forecast – Geographic Distribution (2009 - 2020) 8.17 Non-Hodgkin Lymphoma Number of New Cases 8.17.1 Non-Hodgkin Lymphoma Cancer Number of New Cases & Forecast – Geographic Distribution (2009 - 2020) 8.18 Oesophagus Number of New Cases 8.18.1 Oesophagus Cancer Number of New Cases & Forecast – Geographic Distribution (2009 - 2020) 8.19 Oral Cavity Number of New Cases 8.19.1 Oral Cavity Cancer Number of New Cases & Forecast – Geographic Distribution (2009 - 2020) 8.20 Other Pharynx Number of New Cases 8.20.1 8.21 Other Pharynx Number of New Cases & Forecast – Geographic Distribution (2009 - 2020) Ovary Cancer Number of New Cases & Clinical Trials 8.21.1 Ovary Cancer Number of New Cases & Forecast – Geographic Distribution (2009 - 2020) 8.21.2 Ovarian Cancer – Tests Being Studied In Clinical Trials 8.22 Pancreas Cancer Number of New Cases 8.22.1 Pancreas Cancer Number of New Cases & Forecast – Geographic Distribution (2009 - 2020) © Renub Research Page 11 of 19
  12. 12. 8.23 Prostate Cancer Number of New Cases & Clinical Trials 8.23.1 Prostate Cancer Number of New Cases & Forecast – Geographic Distribution (2009 -2020) 8.23.2 Prostate Cancer – Test Being Studied in Clinical Trials 8.24 Stomach Cancer Number of New Cases 8.24.1 8.25 Testis Cancer Number of New Cases 8.25.1 8.26 Testis Cancer Number of New Cases & Forecast – Geographic Distribution (2009 - 2020) Thyroid Cancer Number of New Cases 8.26.1 8.27 Stomach Cancer Number of New Cases & Forecast – Geographic Distribution (2009 - 2020) Thyroid Cancer Number of New Cases & Forecast – Geographic Distribution (2009 - 2020) Other Sites – Number of New Cases © Renub Research Page 12 of 19
  13. 13. List of Figures Figure 2-1: Global – Cancer Test Market (Million US$), 2010 – 2012 Figure 2-2: Global – Forecast for Cancer Test Market (Million US$), 2013 – 2018 Figure 2-3: Global – Number of New Cancer Cases (Number), 2009 – 2012 Figure 2-4: Global – Forecast for Number of New Cancer Cases (Number), 2013 – 2020 Figure 3-1: Global – Segment Wise Cancer Test Market Share (Percent), 2011 – 2012 Figure 3-2: Global – Forecast for Segment Wise Cancer Test Market Share (Percent), 2013 – 2018 Figure 3-3: Global – Organ Specific Cancer Testing Market Share (Percent), 2010 – 2012 Figure 3-4: Global – Forecast for Organ Specific Cancer Testing Market Share (Percent), 2013 – 2018 Figure 4-1: Global – PSA Test Market (Million US$), 2010 –2012 Figure 4-2: Global – Forecast for PSA Test Market (Million US$), 2013 –2018 Figure 4-3: Global – Fecal Occult Blood Test Market (Million US$), 2009 –2012 Figure 4-4: Global – Forecast for Occult Blood Test Market (Million US$), 2013 –2018 Figure 4-5: Global – FISH Test Market (Million US$), 2010 – 2012 Figure 4-6: Global – Forecast for FISH Test Market (Million US$), 2013 – 2018 Figure 4-7: Global – HPV Test Market (Million US$), 2010 – 2012 Figure 4-8: Global – Forecast for HPV Test Market (Million US$), 2013 – 2018 Figure 4-9: Global – Bladder Cancer Test Market (Million US$), 2010 – 2012 Figure 4-10: Global – Forecast for Bladder Test Market (Million US$), 2013 – 2018 Figure 4-11: Global – Serum Based Cancer Markers Market (Million US$), 2008 – 2012 Figure 4-12: Global – Forecast for Serum Based Cancer Markers Market (Million US$), 2013 – 2018 Figure 4-13: Global – Pharmacognostic Histology Market (Million US$), 2011 – 2012 Figure 4-14: Global – Forecast for Pharmacognostic Histology Market (Million US$), 2013 – 2018 Figure 4-15: Global – Flow Cytometry Market (Million US$), 2011 – 2012 Figure 4-16: Global – Forecast for Flow Cytometry Market (Million US$), 2013 – 2018 Figure 4-17: Global – Other Test Market (Million US$), 2011 – 2012 Figure 4-18: Global – Forecast for Other Test Market (Million US$), 2013 – 2018 Figure 5-1: Global – Bladder Cancer Test Market (Million US$), 2010 – 2012 Figure 5-2: Global – Forecast for Bladder Cancer Test Market (Million US$), 2013 – 2018 Figure 5-3: Global – Breast Cancer Test Market (Million US$), 2010 – 2013 Figure 5-4: Global – Forecast for Breast Cancer Test Market (Million US$), 2013 – 2018 Figure 5-5: Global – Cervical Cancer Test Market (Million US$), 2010 – 2012 Figure 5-6: Global – Forecast for Cervical Cancer Test Market (Million US$), 2013 – 2018 © Renub Research Page 13 of 19
  14. 14. Figure 5-7: Global – Colorectal (Colon) Cancer Test Market (Million US$), 2010 – 2012 Figure 5-8: Global – Forecast for Colorectal (Colon) Cancer Test Market (Million US$), 2013 – 2018 Figure 5-9: Global – Ovarian Cancer Test Market (Million US$), 2010 – 2012 Figure 5-10: Global – Forecast for Ovarian Cancer Test Market (Million US$), 2013 – 2018 Figure 5-11: Global – Prostate Cancer Test Market (Million US$), 2010 – 2012 Figure 5-12: Global – Forecast for Prostate Cancer Test Market (Million US$), 2013 – 2018 Figure 5-13: Global – Liver Cancer Test Market (Million US$), 2010 – 2012 Figure 5-14: Global – Forecast for Liver Cancer Test Market (Million US$), 2013 – 2018 Figure 5-15: Global – Other Organ Cancer Test Market (Million US$), 2010 – 2012 Figure 5-16: Global – Forecast for Other Organ Cancer Test Market (Million US$), 2013 – 2018 Figure 7-1: Africa –Number of New Cancer Cases (Number), 2009 – 2012 Figure 7-2: Africa – Forecast for Number of New Cancer Cases (Number), 2013 – 2020 Figure 7-3: Americas –Number of New Cancer Cases (Number), 2009 – 2012 Figure 7-4: Americas – Forecast for Number of New Cancer Cases (Number), 2013 – 2020 Figure 7-5: Asia –Number of New Cancer Cases (Number), 2009 – 2012 Figure 7-6: Asia – Forecast for Number of New Cancer Cases (Number), 2013 – 2020 Figure 7-7: Europe – Number of New Cancer Cases (Number), 2009 – 2012 Figure 7-8: Europe – Forecast for Number of New Cancer Cases (Number), 2013 – 2020 Figure 7-9: Oceania –Number of New Cancer Cases (Number), 2009 – 2012 Figure 7-10: Oceania – Forecast for Number of New Cancer Cases (Number), 2013 – 2020 © Renub Research Page 14 of 19
  15. 15. List of Tables Table 6-1: Effectiveness of Onko-Sure Within Different Cancer Types Table 6-2: Beckman Coulter – Flow Cytometry Technology portfolio and Various Bundling Options Table 6-3: Beckman Coulter – Hematology Test Product portfolio Table 6-4: bioMérieux – Tumor Markers offerings for Various Cancer Table 8-1: Bladder– Region Wise Number of New Cancer Cases (Number), 2009 – 2012 Table 8-2: Bladder– Forecast for Region Wise Number of New Cancer Cases (Number), 2013 – 2020 Table 8-3: Brain– Region Wise Number of New Cancer Cases (Number), 2009 – 2012 Table 8-4: Brain– Forecast for Region Wise Number of New Cancer Cases (Number), 2013 – 2020 Table 8-5: Breast – Region Wise Number of New Cancer Cases (Number), 2009 – 2012 Table 8-6: Breast– Forecast for Region Wise Number of New Cancer Cases (Number), 2013 – 2020 Table 8-7: Cervix– Region Wise Number of New Cancer Cases (Number), 2009 – 2012 Table 8-8: Cervix– Forecast for Region Wise Number of New Cancer Cases (Number), 2013 – 2020 Table 8-9: Colorectal– Region Wise Number of New Cancer Cases (Number), 2009 – 2012 Table 8-10: Colorectal– Forecast for Region Wise Number of New Cancer Cases (Number), 2013 – 2020 Table 8-11: Corpus– Region Wise Number of New Cancer Cases (Number), 2009 – 2012 Table 8-12: Corpus– Forecast for Region Wise Number of New Cancer Cases (Number), 2013 – 2020 Table 8-13: Hodgkin’s Lymphoma– Region Wise Number of New Cancer Cases (Number), 2009 – 2012 Table 8-14: Hodgkin’s Lymphoma – Forecast for Region Wise Number of New Cancer Cases (Number), 2013 – 2020 Table 8-15: Kaposi Sarcoma – Region Wise Number of New Cancer Cases (Number), 2009 – 2012 Table 8-16: Kaposi Sarcoma– Forecast for Region Wise Number of New Cancer Cases (Number), 2013 – 2020 Table 8-17: Kidney– Region Wise Number of New Cancer Cases (Number), 2009 – 2012 Table 8-18: Kidney– Forecast for Region Wise Number of New Cancer Cases (Number), 2013 – 2020 Table 8-19: Larynx– Region Wise Number of New Cancer Cases (Number), 2009 – 2012 Table 8-20: Larynx– Forecast for Region Wise Number of New Cancer Cases (Number), 2013 – 2020 Table 8-21: Leukaemia – Region Wise Number of New Cancer Cases (Number), 2009 – 2012 Table 8-22: Leukaemia– Forecast for Region Wise Number of New Cancer Cases (Number), 2013 – 2020 Table 8-23: Liver – Region Wise Number of New Cancer Cases (Number), 2009 – 2012 Table 8-24: Liver– Forecast for Region Wise Number of New Cancer Cases (Number), 2013 – 2020 Table 8-25: Lung – Region Wise Number of New Cancer Cases (Number), 2009 – 2012 Table 8-26: Lung– Forecast for Region Wise Number of New Cancer Cases (Number), 2013 – 2020 Table 8-27: Melanoma– Region Wise Number of New Cancer Cases (Number), 2009 – 2012 Table 8-28: Melanoma– Forecast for Region Wise Number of New Cancer Cases (Number), 2013 – 2020 © Renub Research Page 15 of 19
  16. 16. Table 8-29: Myeloma– Region Wise Number of New Cancer Cases (Number), 2009 – 2012 Table 8-30: Myeloma– Forecast for Region Wise Number of New Cancer Cases (Number), 2013 – 2020 Table 8-31: Nasopharynx – Region Wise Number of New Cancer Cases (Number), 2009 – 2012 Table 8-32: Nasopharynx– Forecast for Region Wise Number of New Cancer Cases (Number), 2013 – 2020 Table 8-33: Non-Hodgkin Lymphoma – Region Wise Number of New Cancer Cases (Number), 2009 – 2012 Table 8-34: Non-Hodgkin Lymphoma – Forecast for Region Wise Number of New Cancer Cases (Number), 2013 – 2020 Table 8-35: Oesophagus – Region Wise Number of New Cancer Cases (Number), 2009 – 2012 Table 8-36: Oesophagus – Forecast for Region Wise Number of New Cancer Cases (Number), 2013 – 2020 Table 8-37: Oral Cavity– Region Wise Number of New Cancer Cases (Number), 2009 – 2012 Table 8-38: Oral Cavity – Forecast for Region Wise Number of New Cancer Cases (Number), 2013 – 2020 Table 8-39: Other Pharynx – Region Wise Number of New Cancer Cases (Number), 2009 – 2012 Table 8-40: Other Pharynx – Forecast for Region Wise Number of New Cancer Cases (Number), 2013 – 2020 Table 8-41: Ovary – Region Wise Number of New Cancer Cases (Number), 2009 – 2012 Table 8-42: Ovary – Forecast for Region Wise Number of New Cancer Cases (Number), 2013 – 2020 Table 8-43: Pancreas – Region Wise Number of New Cancer Cases (Number), 2009 – 2012 Table 8-44: Pancreas – Forecast for Region Wise Number of New Cancer Cases (Number), 2013 – 2020 Table 8-45: Prostate – Region Wise Number of New Cancer Cases (Number), 2009 – 2012 Table 8-46: Prostate – Forecast for Region Wise Number of New Cancer Cases (Number), 2013 – 2020 Table 8-47: Stomach – Region Wise Number of New Cancer Cases (Number), 2009 – 2012 Table 8-48: Stomach – Forecast for Region Wise Number of New Cancer Cases (Number), 2013 – 2020 Table 8-49: Testis – Region Wise Number of New Cancer Cases (Number), 2009 – 2012 Table 8-50: Testis – Forecast for Region Wise Number of New Cancer Cases (Number), 2013 – 2020 Table 8-51: Thyroid – Region Wise Number of New Cancer Cases (Number), 2009 – 2012 Table 8-52: Thyroid – Forecast for Region Wise Number of New Cancer Cases (Number), 2013 – 2020 Table 8-53: Other Sites – Region Wise Number of New Cancer Cases (Number), 2009 – 2012 Table 8-54: Other Sites – Forecast for Region Wise Number of New Cancer Cases (Number), 2013 – 2020 © Renub Research Page 16 of 19
  17. 17. Order Form Scan and e-mail this page to info@renub.com. Else you can also fax this form to +91-120-4249780 Questions? Please call +91-120-421-9822 (India), +1-678-302-0700 (USA) or mail to info@renub.com Format Report Title: Cancer Test Market & Forecast, Companies Cancer Test Platform, Pipeline Analysis and Clinical Trials – Global Single User (Email from Publisher) Hard Copy (Mail Delivery) CD – Rom (Mail Delivery) Global Site License (Multiple User License) US$ 1,590 US$ 1,840 US$ 1,690 US$ 2,300 For ordering this report: Three easy ways to place your order: 1) Order online by Credit Card (Visa, MasterCard, etc.): http://www.renub.com/report/cancer-test-market-forecast-companies-cancer-test-platformpipeline-analysis-and-clinical-trials---global-125 2) Order by Wire Transfer: http://www.renub.com/report/wiretransfer.aspx?id=125&pid=1497 To pay by Wire Transfer, please, fill in your contact details in the form below: © Renub Research Page 17 of 19
  18. 18. Bank Details Account Name: Renub Research A/C No.: 109102000023296 Name of Bank: IDBI Bank Ltd. Swift Code: IBKLINBB010 Bank Address: 4th Floor Indian Red Cross Building 1 Red Cross Road Opposite Parliament Street New Delhi – 110001 India Contact Information First Name: Last Name: Email: Job Title: Company: Address: City: Postal/Zip Code: Country: Phone: Mobile: Fax: Report Format: Your message: © Renub Research Page 18 of 19
  19. 19. 3) Order by Check Please post the check accompanied by this form, to: Company Address: Renub Research 1st Floor, C-86, Sector-10 Noida - 201301 Uttar Pradesh India Phone: +91-120-421-9822, 424-9780 For free Sample copy report or to view any of our sample work please contact us at info@renub.com or call +91-120-421-9822 (India), +1-678-302-0700 (USA) Follow Us Facebook: http://www.facebook.com/pages/Renub-Research/233380966701090 LinkedIn: http://www.linkedin.com/company/renub-research Twitter: http://twitter.com/RenubResearch © Renub Research Page 19 of 19

×